Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Florian Moik, Jakob Riedl, Dominik Barth, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Höller, Thorsten Fuereder, Philipp Jost, Ingrid Pabinger, Matthias Preusser, Cihan Ay

Blood (2022) 140 (Supplement 1): 1250–1251.

https://doi.org/10.1182/blood-2022-160087

Published: 2022

Journal Articles

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Florian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Hoeller, Felix Tuchmann, Marie-Bernadette Aretin, Thorsten Fuereder, Sabine Zöchbauer-Müller, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Blood (2021) 137 (12): 1669–1678.

https://doi.org/10.1182/blood.2020007878

Published: 2021

Includes: Supplemental data

Journal Articles

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Julia Riedl, Matthias Preusser, Pegah Mir Seyed Nazari, Florian Posch, Simon Panzer, Christine Marosi, Peter Birner, Johannes Thaler, Christine Brostjan, Daniela Lötsch, Walter Berger, Johannes A. Hainfellner, Ingrid Pabinger, Cihan Ay

Blood (2017) 129 (13): 1831–1839.

https://doi.org/10.1182/blood-2016-06-720714

Published: 2017

Includes: Supplemental data

Journal Articles

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

Felix Sahm, David Capper, Matthias Preusser, Jochen Meyer, Albrecht Stenzinger, Felix Lasitschka, Anna-Sophie Berghoff, Antje Habel, Marion Schneider, Andreas Kulozik, Ioannis Anagnostopoulos, Leonhard Müllauer, Gunhild Mechtersheimer, Andreas von Deimling

Blood (2012) 120 (12): e28–e34.

https://doi.org/10.1182/blood-2012-06-429597

Published: 2012

Includes: Supplemental data

Journal Articles

High Soluble P-Selectin and Low Platelet Count as Thrombosis Risk Markers in Glioma Patients.

Rainer Vormittag, Christine Marosi, Prof., Cihan Ay, Ralph Simanek, Ilse Schwarzinger, Matthias Preusser, Katarzyna Elandt, Christoph C Zielinski, Ingrid Pabinger

Blood (2009) 114 (22): 2985.

https://doi.org/10.1182/blood.V114.22.2985.2985

Published: 2009

NARROW

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

High Soluble P-Selectin and Low Platelet Count as Thrombosis Risk Markers in Glioma Patients.

Email alerts

ASH Publications

American Society of Hematology

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

High Soluble P-Selectin and Low Platelet Count as Thrombosis Risk Markers in Glioma Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only